Occam Places CBO at A-Alpha Bio
In September 2025, Occam Global, a leader in executive recruiting for TechBio, placed Troy Lionberger, PhD, as CBO of A-Alpha Bio.
Lionberger is a proven platform strategist and dealmaker with over a decade of experience in forming high-value partnerships across various markets, including pharmaceuticals, agriculture, and industrial biotechnology. Before joining A-Alpha, he served as the CBO at Abbratech and spent nearly ten years at Berkeley Lights, where he held R&D and business development roles. He led commercial initiatives that secured more than $200M in signed deals, including partnerships with Ginkgo Bioworks, Thermo Fisher Scientific, and Bayer Crop Science. His cross-functional expertise also helped steer the company through its IPO and its eventual acquisition by Bruker Corporation.
Lionberger earned two undergraduate degrees from UC Berkeley in Molecular and Cell Biology and Bioengineering, as well as a Master's in Mechanical Engineering and a PhD in Cellular and Molecular Biology from the University of Michigan.
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.